Abound Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.5K | Buy |
45
+9
| +25% | +$4.71K | 0.01% | 305 |
|
|
2025
Q1 | $23K | Sell |
36
-3
| -8% | -$1.91K | 0.01% | 276 |
|
|
2024
Q4 | $28K | Sell |
39
-2
| -5% | -$1.44K | 0.01% | 234 |
|
|
2024
Q3 | $43.2K | Buy |
41
+4
| +11% | +$4.21K | 0.01% | 194 |
|
|
2024
Q2 | $39.3K | Buy |
37
+2
| +6% | +$2.12K | 0.01% | 178 |
|
|
2024
Q1 | $33.8K | Buy |
35
+3
| +9% | +$2.9K | 0.01% | 184 |
|
|
2023
Q4 | $27.8K | Buy |
32
+7
| +28% | +$6.07K | 0.01% | 209 |
|
|
2023
Q3 | $20.6K | Buy |
25
+6
| +32% | +$4.95K | 0.01% | 216 |
|
|
2023
Q2 | $13.4K | Buy |
19
+5
| +36% | +$3.52K | 0.01% | 288 |
|
|
2023
Q1 | $11.5K | Buy |
14
+4
| +40% | +$3.29K | 0.01% | 272 |
|
|
2022
Q4 | $7.22K | Sell |
10
-6
| -38% | -$4.33K | ﹤0.01% | 304 |
|
|
2022
Q3 | $11K | Buy |
+16
| New | +$11K | 0.01% | 262 |
|